查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2018795

疼痛管理設備市場：2026-2032年全球市場預測（按設備類型、應用程式、分銷管道、最終用戶和購買方式分類）

Pain Management Devices Market by Device Type, Application, Distribution Channel, End User, Mode of Purchase - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，疼痛管理設備市場價值將達到 39.7 億美元，到 2026 年將成長至 43.2 億美元，到 2032 年將達到 73.2 億美元，複合年成長率為 9.11%。

主要市場統計數據
基準年 2025 39.7億美元
預計年份：2026年 43.2億美元
預測年份 2032 73.2億美元
複合年成長率 (%) 9.11%

清晰的策略方向，掌握不斷變化的臨床、商業和法規環境，從而塑造現代疼痛管理設備策略。

本執行摘要首先為複雜且快速發展的疼痛管理設備領域提供循證指導，明確概述了本報告的目標及其為臨床、商業和政策相關人員帶來的價值。

臨床偏好的改變、醫療保健的去中心化、數位整合以及不斷變化的監管期望正在重新定義疼痛管理設備的產品和商業策略。

疼痛管理設備產業正在經歷幾項變革性的變化，這些變化正在改變臨床工作流程、產品生命週期和商業重點。

2025 年實施的累積關稅措施以及由此對我們的供應鏈和採購結構所做的調整，已經重組了我們的成本結構、供應商策略和產品發布計劃。

2025 年實施的累積關稅措施給整個醫療設備供應鏈的採購流程帶來了更大的成本壓力和複雜性，給製造商和下游醫療保健提供者帶來了營運負擔。

將醫療設備類型、臨床應用、通路、最終用戶醫療保健環境和購買方式與市場進入選項聯繫起來的全面細分洞察。

市場區隔洞察揭示了臨床需求、技術適用性和商業性路徑如何在醫療設備類型、應用、分銷管道、最終用戶和購買方式等各種要素之間相互交織。依器械類型分類，市場涵蓋鎮痛輸注泵、電刺激器械、磁療器械和射頻消融術器械。進一步的分類包括：輸注系統中的鞘內幫浦和病人自控式鎮痛（PCA）幫浦；以及電刺激技術中的微電流治療、神經肌肉電刺激和經皮電神經刺激等電刺激器材。射頻消融術技術可進一步細分為雙極、單極和脈衝射頻三種方法。這些區別直接關係到手術的基礎設施要求、臨床醫生的培訓需求以及報銷要求，因此在製定商業化策略中起著至關重要的作用。

美洲、歐洲、中東和非洲以及亞太地區的獨特區域趨勢和營運重點，塑造了市場進入和商業化策略。

區域趨勢影響臨床實踐模式、報銷框架和供應鏈物流，為產品優先排序和市場進入策略提供了關鍵見解。在美洲，醫療保健系統以公立和私立保險公司並存為特徵，高度重視治療效果和實證應用。這種環境重視那些能夠展現顯著臨床差異化和成本效益，並能與綜合醫療保健網路建立合作關係的醫療設備。在歐洲、中東和非洲，不同的管理體制和報銷途徑需要製定個人化的監管策略和在地化的臨床檢驗。此外，地緣政治環境也會影響植入式和高成本治療性醫療設備製造商的採購決策和部署計畫。

成熟的製造商、神經調控專家和軟體主導創新者如何透過臨床證據、夥伴關係和可擴展的生產來建立競爭優勢。

疼痛管理設備的競爭格局由成熟的醫療設備製造商、專注於神經調控技術的創新者以及強調軟體驅動治療管理的新興數位療法公司組成。大型公司正努力透過投資臨床試驗、收集可靠的上市後證據以及開展強力的臨床醫生互動計畫來贏得處方醫生和採購集團的信任。同時，一些專注於特定領域的企業和Start-Ups正在推動微創射頻消融術技術、穿戴式電刺激療法以及支援遠端劑量調整和用藥依從性監測的連網輸液幫浦解決方案等領域的快速創新。

醫療設備製造商採取切實可行的策略步驟，使設計、證據、供應鏈和經營模式與分散式醫療保健和支付方的期望保持一致。

尋求維持或確立市場領先地位的產業領導企業應採取整合產品設計、臨床證據產生和商業性執行的策略，以適應分散式醫療保健和支付方嚴格審查的現實情況。首先，應在早期設計決策中納入價值鏈風險評估和組件採購柔軟性，從而降低產品供應受政策變化和關稅波動的影響。同時，應優先考慮模組化產品架構和軟體優先設計，以實現快速迭代開發、遠端更新以及添加增值數位服務，從而支援用藥依從性和治療結果追蹤。

嚴謹而多方面的研究途徑，結合專家訪談、臨床和監管分析以及供應鏈映射，確保檢驗且可操作的見解。

本分析的調查方法融合了定性訪談、文獻資料整合、監管和臨床試驗審查以及供應鏈分析，以確保獲得全面而深入的洞察。主要資訊來源包括對不同疼痛管理專科的臨床醫生、醫院和綜合醫療網路的採購經理、醫療設備製造商的產品開發經理以及供應鏈和監管專家的結構化檢驗。這些訪談旨在收集關於可用性、臨床可接受性和採購標準的實際觀點。

整合不斷變化的疼痛管理設備市場中的策略挑戰，強調敏捷性、證據整合和夥伴關係主導的商業化。

總之，疼痛管理設備市場正進入一個以目標明確的創新、醫療保健去中心化以及治療硬體與數位化能力的進一步融合為特徵的階段。這些因素正在推動產品在易用性、實證醫學以及超越設備本身的服務主導型交付模式方面的差異化。那些從產品設計初期就考慮供應鏈韌性、將資料收集整合到臨床工作流程中，並根據特定臨床應用和終端用戶環境定製商業化策略的企業，將更有利於實現永續價值。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 疼痛管理設備市場：依設備類型分類

  • 鎮痛輸注泵
    • 脊髓內泵
    • 患者自控鎮痛泵
  • 電刺激設備
    • 用於微電流療法的電刺激裝置
    • 神經肌肉電刺激
    • 經皮電神經刺激
  • 磁療設備
  • 射頻消融術裝置
    • 雙極射頻消融術
    • 單極射頻消融術
    • 脈衝射頻消融術

第9章 疼痛管理設備市場：依應用領域分類

  • 癌症疼痛管理
  • 月經疼痛管理
  • 肌肉骨骼疼痛管理
    • 關節疼痛
    • 腰痛
  • 神經性疼痛管理
  • 術後疼痛管理
    • 術後急性疼痛
    • 慢性術後疼痛

第10章 疼痛管理設備市場：依通路分類

  • 離線
  • 線上

第11章 疼痛管理設備市場：依最終用戶分類

  • 居家照護環境
    • 慢性病居家照護
    • 術後居家照護
  • 醫院和診所
    • 一般診所
    • 疼痛診所
  • 長期照護機構
    • 安寧療護
    • 護理機構

第12章 疼痛管理設備市場：依購買類型分類

  • 市售產品
  • 處方箋藥

第13章 疼痛管理設備市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 疼痛管理設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 疼痛管理設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國疼痛管理設備市場

第17章：中國疼痛管理設備市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • AVACEN, Inc.
  • Avanos Medical, Inc.
  • B. Braun SE
  • BioElectronics Corporation
  • Boston Scientific Corporation
  • CEFALY Technology
  • Enovis Corporation
  • Healthmate International, LLC
  • HMS Medical Systems
  • ICU Medical, Inc.
  • iTENS, LLC
  • Johari Digital
  • Kimberly-Clark Corporation
  • Medtronic PLC
  • Multi Radiance Medical, Inc.
  • NeuroMetrix, Inc.
  • Nevro Corp.
  • OMRON Healthcare, Inc.
  • Oska Wellness
  • Pain Care Labs
  • Pain Management Technologies, Inc.
  • Pfizer, Inc.
  • Sanofi SA
  • Stryker Corporation
  • Ultracare Pro by Zealmax Innovations Pvt. Ltd.
  • Zynex, Inc.
Product Code: MRR-ED54C46E8320

The Pain Management Devices Market was valued at USD 3.97 billion in 2025 and is projected to grow to USD 4.32 billion in 2026, with a CAGR of 9.11%, reaching USD 7.32 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.97 billion
Estimated Year [2026] USD 4.32 billion
Forecast Year [2032] USD 7.32 billion
CAGR (%) 9.11%

A clear and strategic orientation that frames the evolving clinical, commercial, and regulatory environment shaping modern pain management device strategies

This executive summary opens with an evidence-based orientation to the complex, rapidly evolving field of pain management devices, articulating the purpose of the report and the value it provides to clinical, commercial, and policy stakeholders.

The introduction establishes context by highlighting converging forces that influence product development and adoption, including the shift toward non-opioid therapeutic strategies, the rise of outpatient and home-based care models, and growing integration of digital health capabilities with device platforms. These dynamics are reshaping clinical pathways and decision-making criteria for physicians, hospital administrators, and payers alike. The narrative underscores the need for device makers and service providers to reexamine product portfolios, go-to-market models, and collaborative partnerships in light of clinical preference changes and patient-centric care trends.

Additionally, this section outlines the report's analytical framework and the types of evidence synthesized, clarifying how regulatory considerations, reimbursement pressures, supply chain resilience, and technological convergence inform the insights that follow. By framing key questions around safety, efficacy, usability, and integration, the introduction sets up a pragmatic lens through which readers can interpret subsequent sections and apply findings to product strategy, market entry planning, and investment assessment.

How clinical preference shifts, decentralization of care, digital integration, and evolving regulatory expectations are redefining product and commercial strategies in pain management devices

The landscape of pain management devices is undergoing several transformative shifts that alter clinical workflows, product lifecycles, and commercial priorities.

First, there is a pronounced move toward neuromodulation and minimally invasive interventions as clinicians seek durable, non-pharmacologic modalities to reduce reliance on systemic analgesics. This trend has elevated research into electrical stimulation, radiofrequency techniques, and magnetic therapies that target specific pain pathways while preserving patient mobility and reducing long-term medication exposure. Second, care delivery is decentralizing; devices designed for safe, effective use in home care settings are gaining strategic importance because they support shorter hospital stays and resonate with patient preferences for convenience and privacy. Third, digital augmentation-ranging from remote monitoring and device telemetry to app-based therapy titration and adherence tools-is increasingly a differentiator for both clinical outcomes and payer reimbursement conversations.

Concurrently, regulatory pathways and evidence requirements are evolving to emphasize real-world performance and post-market surveillance, prompting manufacturers to invest in data generation capabilities. Supply chain resilience and component sourcing strategies have become central to product continuity, while strategic partnerships between device companies and service providers accelerate route-to-patient timelines. Together, these shifts require organizations to adopt integrated strategies that align clinical validation, regulatory planning, and commercial execution to remain competitive and relevant.

The 2025 cumulative tariff measures and the resultant supply chain and procurement adjustments that reshaped cost profiles, supplier strategies, and product launch timetables

Cumulative tariff actions implemented in 2025 have introduced amplified cost pressures and procurement complexities across medtech supply chains, creating operational stress for manufacturers and downstream providers.

Tariffs applied to key imported components and subassemblies have increased landed costs for device manufacturers that rely on international sourcing of electronic modules, precision components, and specialized polymers. In response, many organizations undertook near-term cost mitigation measures such as renegotiating supplier contracts, increasing inventory buffers, and accelerating efforts to qualify alternate suppliers from less-impacted jurisdictions. These short-term responses helped stabilize production but introduced margin compression and, in some cases, delayed product launches due to extended validation timelines.

Over the same period, procurement teams and health systems adjusted purchasing strategies, prioritizing suppliers with diversified supply chains or local manufacturing footprints to reduce exposure to trade dynamics. Across the ecosystem, the tariffs catalyzed strategic review of vertical integration options and increased emphasis on design-for-supply resilience during product development. Importantly, these changes also intensified collaboration between commercial and regulatory functions to ensure that component substitutions complied with device safety and validation requirements. Looking ahead, organizations that integrate tariff risk assessment into early-stage product design and maintain flexible supplier networks are positioned to navigate similar policy shifts with less operational disruption.

Comprehensive segmentation insights that connect device types, clinical applications, distribution routes, end-user care settings, and purchase modes to commercialization choices

Segmentation insights illuminate where clinical need, technology fit, and commercial pathways intersect across device type, application, distribution channel, end user, and purchase mode. Based on device type, the market spans analgesic infusion pumps, electrical stimulation devices, magnetic therapy devices, and radiofrequency ablation devices, with further granularity that differentiates intrathecal pumps and patient-controlled analgesia pumps within infusion systems, and microcurrent therapy E-Stim devices, neuromuscular electrical stimulation, and transcutaneous electrical nerve stimulation within electrical stimulation technologies; radiofrequency ablation modalities are further distinguished by bipolar, monopolar, and pulsed RF approaches. These distinctions are material because they align directly with procedural infrastructure requirements, clinician training needs, and reimbursement descriptors, thereby informing commercialization strategy.

Based on application, devices are deployed across cancer pain management, menstrual pain management, musculoskeletal pain management, neuropathic pain management, and post-operative pain management, where musculoskeletal care subdivides into arthritis pain and back pain and post-operative care differentiates between acute post-surgical pain and chronic surgical pain. Clinical utilization patterns across these applications shape product feature priorities, patient selection criteria, and evidence generation plans. Based on distribution channel, end users and purchase pathways vary between offline channels, such as hospitals and clinics, and online channels that serve direct-to-patient models and digital platforms; this split dictates marketing, service, and logistics approaches. Based on end user, the landscape includes home care settings, hospitals and clinics, and long-term care centers, with home care further segmented into chronic illness home care and post-surgery home care, hospitals and clinics differentiating neutral clinics from specialized pain clinics, and long-term care centers including hospices and nursing homes-each setting requires distinct usability, training, and maintenance considerations. Based on mode of purchase, the dichotomy of over-the-counter and prescription-based acquisition defines regulatory pathways, labeling, and clinician involvement in therapy initiation. Together, these segmentation layers provide a practical framework for prioritizing product development, channel strategies, and clinical evidence plans to match each distinct use case and buyer persona.

Distinct regional dynamics and operational priorities across the Americas, Europe, Middle East & Africa, and Asia-Pacific that determine market access and commercialization tactics

Regional dynamics influence clinical practice patterns, reimbursement frameworks, and supply chain logistics, creating important implications for product prioritization and market entry approaches. In the Americas, healthcare systems are characterized by a mix of private and public payers, with a strong emphasis on outcomes and evidence-based adoption; this environment rewards devices that deliver demonstrable clinical differentiation and cost-effectiveness while enabling partnerships with integrated delivery networks. In Europe, Middle East & Africa, diverse regulatory regimes and varying reimbursement pathways require tailored regulatory strategies and local clinical validation, and the geopolitical landscape shapes sourcing decisions and deployment timelines for manufacturers of implantable and high-cost therapeutic devices.

Asia-Pacific features heterogeneous markets with rapidly growing demand for outpatient and home-based solutions, rising adoption of digital health tools, and substantial local manufacturing capacity that can support cost-competitive sourcing and faster time-to-market in regional hubs. Across all regions, regional supply chain resilience and the ability to navigate local clinical guidelines and payer expectations remain critical, but the operational priorities differ: the Americas often prioritize rigorous clinical outcomes and integrated care partnerships, Europe, Middle East & Africa call for regulatory navigation and local stakeholder engagement, and Asia-Pacific emphasizes scalability, affordability, and digital-enabled care delivery. Recognizing these contrasts is essential for tailoring market access strategies and regional investment plans.

How established manufacturers, neuromodulation specialists, and software-driven innovators are shaping competitive advantage through clinical evidence, partnerships, and scalable manufacturing

Competitive dynamics in pain management devices reflect a blend of established medical device manufacturers, specialized neuromodulation innovators, and emerging digital therapeutics firms that emphasize software-enabled therapeutic management. Leading organizations tend to combine clinical trial investment with robust post-market evidence collection and strong clinician engagement programs to build trust among prescribers and purchasing groups. At the same time, niche players and start-ups drive rapid innovation in areas such as minimally invasive radiofrequency ablation techniques, wearable electrical stimulation modalities, and connected infusion pump solutions that support remote titration and adherence monitoring.

Manufacturers that pair hardware expertise with software capabilities and data analytics gain a practical advantage in delivering outcome-tracking and reimbursement-ready evidence. Contract manufacturers and component suppliers play a pivotal role in accelerating time-to-market, particularly for companies seeking to optimize manufacturing capacity without large capital expenditures. Strategic partnerships between device firms and digital health service providers are increasingly common, enabling bundled solutions that integrate therapy delivery, remote monitoring, and patient engagement. Investors and acquirers are attentive to organizations demonstrating regulatory maturity, scalable manufacturing, and credible clinical evidence pathways, while service providers that can support post-market surveillance and real-world data capture become indispensable collaborators in commercialization strategies.

Actionable strategic moves for device makers to align design, evidence, supply chain, and commercial models with decentralized care and payer expectations

Industry leaders seeking to maintain or build market leadership should adopt integrated strategies that align product design, clinical evidence generation, and commercial execution to the realities of decentralized care and payer scrutiny. Begin by embedding supply chain risk assessment and component sourcing flexibility into early-stage design decisions so that product availability is less sensitive to policy shifts and tariff volatility. Simultaneously, prioritize modular product architectures and software-first designs that enable rapid iteration, remote updates, and the addition of value-added digital services that support adherence and outcomes tracking.

Invest in pragmatic evidence generation that combines focused randomized studies with real-world data collection to demonstrate clinical benefit across prioritized applications, such as musculoskeletal and post-operative pain, and to support reimbursement discussions with payers. Strengthen commercial relationships by tailoring go-to-market models to the distribution channel and end-user profile, distinguishing strategies for home care, outpatient clinics, and specialized pain centers. Finally, pursue partnerships with contract manufacturers, specialty suppliers, and digital health firms to accelerate time-to-market while preserving capital efficiency. Taken together, these actions help firms reduce time-to-adoption, mitigate operational risk, and secure a defensible position in a market that increasingly values integrated clinical and digital solutions.

A rigorous, multi-source research approach combining expert interviews, clinical and regulatory analysis, and supply chain mapping to ensure validated and actionable insights

The research methodology underpinning this analysis integrates primary qualitative interviews, document and literature synthesis, regulatory and clinical trial review, and supply chain mapping to ensure robust, triangulated insights. Primary inputs include structured interviews with clinicians across specialties that manage pain, procurement leaders within hospitals and integrated delivery networks, product development leaders at device companies, and supply chain and regulatory specialists. These conversations were designed to capture frontline perspectives on usability, clinical acceptance, and procurement criteria.

Secondary investigation incorporated peer-reviewed clinical literature, regulatory filings, patent landscapes, and publicly available clinical trial registries to assess safety profiles, procedural adoption, and evidence maturity; cross-referencing these sources ensured consistency with practitioner-reported trends. Supply chain analysis examined component sourcing, manufacturing footprints, and logistics vulnerabilities to contextualize tariff impacts and procurement responses. Finally, findings were subjected to iterative validation through expert review panels to confirm interpretive accuracy, clarify ambiguous patterns, and refine practical recommendations for stakeholders seeking to align product strategy with evolving clinical and commercial conditions.

Synthesis of strategic imperatives emphasizing agility, evidence integration, and partnership-driven commercialization in the evolving pain management device market

In conclusion, the pain management device landscape is entering a phase characterized by purposeful innovation, decentralization of care, and greater integration of digital capabilities with therapeutic hardware. These forces are driving differentiation around usability, evidence generation, and service-enabled offerings that extend beyond the device itself. Organizations that respond by aligning early-stage product design with supply chain resilience, by integrating data collection into clinical workflows, and by tailoring commercialization strategies to specific clinical applications and end-user settings will be better positioned to capture sustainable value.

Moreover, the interplay of trade policy, reimbursement complexity, and clinician preference means that organizational agility-expressed through flexible supplier relationships, modular product development, and adaptive regulatory strategies-will be a defining characteristic of successful companies. The strategic path forward emphasizes partnerships, digital integration, and pragmatic evidence generation as core competencies. Firms that cultivate these capabilities can better meet clinician needs, improve patient outcomes, and create compelling value propositions for payers and health systems alike.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Pain Management Devices Market, by Device Type

  • 8.1. Analgesic Infusion Pumps
    • 8.1.1. Intrathecal Pumps
    • 8.1.2. Patient-Controlled Analgesia Pumps
  • 8.2. Electrical Stimulation Devices
    • 8.2.1. Microcurrent Therapy E-Stim Devices
    • 8.2.2. Neuromuscular Electrical Stimulation
    • 8.2.3. Transcutaneous Electrical Nerve Stimulation
  • 8.3. Magnetic Therapy Devices
  • 8.4. Radiofrequency Ablation Devices
    • 8.4.1. Bipolar RF Ablation
    • 8.4.2. Monopolar RF Ablation
    • 8.4.3. Pulsed RF Ablation

9. Pain Management Devices Market, by Application

  • 9.1. Cancer Pain Management
  • 9.2. Menstrual Pain Management
  • 9.3. Musculoskeletal Pain Management
    • 9.3.1. Arthritis Pain
    • 9.3.2. Back Pain
  • 9.4. Neuropathic Pain Management
  • 9.5. Post-Operative Pain Management
    • 9.5.1. Acute Post-Surgical Pain
    • 9.5.2. Chronic Surgical Pain

10. Pain Management Devices Market, by Distribution Channel

  • 10.1. Offline
  • 10.2. Online

11. Pain Management Devices Market, by End User

  • 11.1. Home Care Settings
    • 11.1.1. Chronic Illness Home Care
    • 11.1.2. Post-Surgery Home Care
  • 11.2. Hospitals And Clinics
    • 11.2.1. Neutral Clinics
    • 11.2.2. Pain Clinics
  • 11.3. Long-Term Care Centers
    • 11.3.1. Hospices
    • 11.3.2. Nursing Homes

12. Pain Management Devices Market, by Mode of Purchase

  • 12.1. Over-the-counter
  • 12.2. Prescription-based

13. Pain Management Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Pain Management Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Pain Management Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Pain Management Devices Market

17. China Pain Management Devices Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. AVACEN, Inc.
  • 18.7. Avanos Medical, Inc.
  • 18.8. B. Braun SE
  • 18.9. BioElectronics Corporation
  • 18.10. Boston Scientific Corporation
  • 18.11. CEFALY Technology
  • 18.12. Enovis Corporation
  • 18.13. Healthmate International, LLC
  • 18.14. HMS Medical Systems
  • 18.15. ICU Medical, Inc.
  • 18.16. iTENS, LLC
  • 18.17. Johari Digital
  • 18.18. Kimberly-Clark Corporation
  • 18.19. Medtronic PLC
  • 18.20. Multi Radiance Medical, Inc.
  • 18.21. NeuroMetrix, Inc.
  • 18.22. Nevro Corp.
  • 18.23. OMRON Healthcare, Inc.
  • 18.24. Oska Wellness
  • 18.25. Pain Care Labs
  • 18.26. Pain Management Technologies, Inc.
  • 18.27. Pfizer, Inc.
  • 18.28. Sanofi S.A.
  • 18.29. Stryker Corporation
  • 18.30. Ultracare Pro by Zealmax Innovations Pvt. Ltd.
  • 18.31. Zynex, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PAIN MANAGEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PAIN MANAGEMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY INTRATHECAL PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY INTRATHECAL PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY INTRATHECAL PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PATIENT-CONTROLLED ANALGESIA PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PATIENT-CONTROLLED ANALGESIA PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PATIENT-CONTROLLED ANALGESIA PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MICROCURRENT THERAPY E-STIM DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MICROCURRENT THERAPY E-STIM DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MICROCURRENT THERAPY E-STIM DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUROMUSCULAR ELECTRICAL STIMULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUROMUSCULAR ELECTRICAL STIMULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUROMUSCULAR ELECTRICAL STIMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MAGNETIC THERAPY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MAGNETIC THERAPY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MAGNETIC THERAPY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY BIPOLAR RF ABLATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY BIPOLAR RF ABLATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY BIPOLAR RF ABLATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MONOPOLAR RF ABLATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MONOPOLAR RF ABLATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MONOPOLAR RF ABLATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PULSED RF ABLATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PULSED RF ABLATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PULSED RF ABLATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CANCER PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CANCER PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CANCER PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MENSTRUAL PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MENSTRUAL PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MENSTRUAL PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ARTHRITIS PAIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ARTHRITIS PAIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ARTHRITIS PAIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY BACK PAIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY BACK PAIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY BACK PAIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUROPATHIC PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUROPATHIC PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUROPATHIC PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ACUTE POST-SURGICAL PAIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ACUTE POST-SURGICAL PAIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ACUTE POST-SURGICAL PAIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CHRONIC SURGICAL PAIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CHRONIC SURGICAL PAIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CHRONIC SURGICAL PAIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CHRONIC ILLNESS HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CHRONIC ILLNESS HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CHRONIC ILLNESS HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-SURGERY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-SURGERY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-SURGERY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUTRAL CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUTRAL CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUTRAL CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PAIN CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PAIN CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PAIN CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NURSING HOMES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NURSING HOMES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NURSING HOMES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY OVER-THE-COUNTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY OVER-THE-COUNTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY OVER-THE-COUNTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PRESCRIPTION-BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PRESCRIPTION-BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PRESCRIPTION-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 154. LATIN AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. LATIN AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2032 (USD MILLION)
  • TABLE 188. MIDDLE EAST PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. MIDDLE EAST PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 192. MIDDLE EAST PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. MIDDLE EAST PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 195. MIDDLE EAST PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 196. MIDDLE EAST PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. MIDDLE EAST PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2032 (USD MILLION)
  • TABLE 202. AFRICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 203. AFRICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. AFRICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 205. AFRICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 206. AFRICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 207. AFRICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. AFRICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 209. AFRICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 210. AFRICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 211. AFRICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. AFRICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 213. AFRICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 214. AFRICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2032 (USD MILLION)
  • TABLE 216. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 219. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 220. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 221. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 223. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 224. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 225. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 227. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 228. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2032 (USD MILLION)
  • TABLE 230. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 231. ASEAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. ASEAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. ASEAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 234. ASEAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 235. ASEAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 236. ASEAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 237. ASEAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 238. ASEAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 239. ASEAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 240. ASEAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 241. ASEAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 242. ASEAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 243. ASEAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 244. ASEAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2032 (USD MILLION)
  • TABLE 245. GCC PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 246. GCC PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. GCC PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 248. GCC PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 249. GCC PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 250. GCC PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 251. GCC PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 252. GCC PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 253. GCC PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 254. GCC PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 255. GCC PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 256. GCC PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 257. GCC PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 258. GCC PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPEAN UNION PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPEAN UNION PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPEAN UNION PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPEAN UNION PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPEAN UNION PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPEAN UNION PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPEAN UNION PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPEAN UNION PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPEAN UNION PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPEAN UNION PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPEAN UNION PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2032 (USD MILLION)
  • TABLE 273. BRICS PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 274. BRICS PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. BRICS PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 276. BRICS PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 277. BRICS PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 278. BRICS PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 279. BRICS PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 280. BRICS PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 281. BRICS PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 282. BRICS PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 283. BRICS PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 284. BRICS PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 285. BRICS PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2032 (USD MILLION)
  • TABLE 286. BRICS PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2032 (USD MILLION)
  • TABLE 287. G7 PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 288. G7 PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 289. G7 PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 290. G7 PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 291. G7 PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 292. G7 PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 293. G7 PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 294. G7 PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 295. G7 PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 296. G7 PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 297. G7 PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2032 (USD MILLION)
  • TABLE 298. G7 PAIN MANAGEMENT DEVICES MAR